Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
News Release
Genex's Sue Ann Knoblauch Wins Platinum Award for Case Management
Two additional Genex case managers recognized as finalistsWAYNE, PA – May 17, 2018 – Genex
Workers' Comp
Article
StateWatch: Bill Review May 2018
Keep current with new legislation and its potential effect on your organization.
Workers' Comp
News Release
Genex receives 2018 Communicator Award for "Robocop: The Jeremy Romero Story"
Video chronicling injured police officer's rise from spinal cord injury recognized by renowned media academy WAYNE, PA - May 16, 2018 - G
Workers' Comp
Blog
Topical Treatments - Their Impact on Drug Spend and Utilization
Workers' Comp
Article
StateWatch: Bill Review May 2018
Keep current with new legislation and its potential effect on your organization.
Mitchell
News Release
Hawaii Legislature Sends Opioid Limits Bill to Governor
The Hawaii Legislature passed SB2244 and sent the legislation to Governor Ige for his signature on May 3, 2018.